Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.

@article{Burks2015SublingualIF,
  title={Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.},
  author={Arvil Wesley Burks and Robert B. Wood and Stacie M. Jones and Scott H. Sicherer and David M. Fleischer and Amy M. Scurlock and Brian P. Vickery and Andrew H. Liu and Alice K. Henning and Robert W. Lindblad and Peter Dawson and Marshall Plaut and Hugh A Sampson},
  journal={The Journal of allergy and clinical immunology},
  year={2015},
  volume={135 5},
  pages={
          1240-8.e1-3
        }
}
BACKGROUND We previously reported the initial results of the first multicenter, randomized, double-blind, placebo-controlled clinical trial of peanut sublingual immunotherapy (SLIT), observing a favorable safety profile associated with modest clinical and immunologic effects in the first year. OBJECTIVE We sought to provide long-term (3-year) clinical and immunologic outcomes for our peanut SLIT trial. Key end points were (1) percentage of responders at 2 years (ie, could consume 5 g of… CONTINUE READING
BETA
Highly Cited
This paper has 73 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
SHOWING 1-10 OF 40 CITATIONS, ESTIMATED 54% COVERAGE

74 Citations

0102020152016201720182019
Citations per Year
Semantic Scholar estimates that this publication has 74 citations based on the available data.

See our FAQ for additional information.

Similar Papers

Loading similar papers…